By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



6275 Nancy Ridge Drive, Suite 110

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a


Organovo (NASDAQ MKT: ONVO) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications.

The Company is collaborating with a variety of pharmaceutical, academic and other partners to develop human biological tissues in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed safer, faster and at lower cost. In addition to numerous scientific publications, our technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and other outlets.

Organovo is changing the shape of life sciences, medical research and practice. Check out our current openings to see how you can “Change the Shape of Your Future at Organovo”.

Key Statistics

Ownership: Public

Web Site: Organovo
Symbol: ONVO


Company News
Organovo (ONVO) And University of California, San Diego (UCSD) Receive $1.7 Million Grant From NIH To Study Liver Disease 7/31/2017 11:05:16 AM
Organovo (ONVO) Announces Release Date For Fiscal First-Quarter 2018 Financial Results 7/18/2017 7:20:16 AM
Organovo (ONVO) Announces Fiscal Fourth-Quarter And Full-Year 2017 Results; Company Issues Full-Year Fiscal 2018 Outlook 6/8/2017 8:26:09 AM
Organovo (ONVO) Presents New Preclinical Data On 3D Bioprinted Human Liver Tissues At World Advanced Therapies And Regenerative Medicine Congress 5/18/2017 9:05:21 AM
Organovo (ONVO) Announces Release Date For Fiscal Fourth-Quarter 2017 Financial Results 5/17/2017 8:38:18 AM
Organovo (ONVO) Collaborates With University of Virginia To Develop Bioprinted Tissues For Volumetric Muscle Loss Injury 5/1/2017 8:34:29 AM
Organovo (ONVO) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4/25/2017 8:16:36 AM
Organovo (ONVO) Announces CEO Transition 4/12/2017 10:50:32 AM
Organovo (ONVO) And Its Customers Present Data Supporting 3D Bioprinted Liver And Kidney Tissues For Drug Toxicity Testing 3/13/2017 8:18:49 AM
Organovo (ONVO) Publishes Data Describing Physiology Of 3D Bioprinted Human Kidney Tissues For Drug Toxicity Testing 2/21/2017 8:33:25 AM